Request Deal Involvement
Shanghai's SARI pays €300m for Italian cancer biopharma NMS Group.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Shanghai Pudong Science and Technology Investment
legal advisors
Pedersoli Studio Legale
financial advisors
Bank of China
legal advisors
Battistella
financial advisors
Houlihan Lokey
legal advisors
White & Case
or
Principals
bidder
SHANGHAI ADVANCED RESEARCH INSTITUTE
target
NMS GROUP SPA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite